Zydelig Prices, Coupons and Patient Assistance Programs
Zydelig (idelalisib) is a member of the PI3K inhibitors drug class and is commonly used for Chronic Lymphocytic Leukemia, Follicular Lymphoma, Lymphoma, and others.
Zydelig prices
The cost for Zydelig oral tablet 100 mg is around $13,098 for a supply of 60 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Zydelig is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Zydelig availability.
This Zydelig price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Oral Tablet
Quantity | Per unit | Price |
---|---|---|
60 | $218.30 | $13,098.11 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Quantity | Per unit | Price |
---|---|---|
60 | $218.30 | $13,098.11 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardPlease note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Zydelig Coupons and Rebates
Zydelig offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Zydelig Copay Coupon Program: Eligible commercially insured patients pay as little as $5 per 30-day supply; for additional information contact the program at 844-622-2377.
- Applies to:
- Zydelig
- Number of uses:
- Per prescription until program expires
Form more information phone: 844-622-2377 or Visit website
Patient Assistance Programs for Zydelig
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Zydelig (idelalisib) Tablet
More information please phone: 866-316-7263 Visit Website
Provider: Zydelig AccessConnect
Elligibility requirements:- May have insurance; must be experiencing financial difficulty
- Not disclosed
- Medically Necessary as determined by a Doctor
- Must be residing in the US or a US territory, and under the care of a US physician
- The ZYDELIG QuickStart Program provides a free 30-day supply for eligible patients who face an insurance coverage delay of more than 5 business days. Co-payment assistance, and patient assistance programs are available for eligible patients.
- Zydelig (idelalisib) Tablet
More information please phone: 844-622-2377 Visit Website
More about Zydelig (idelalisib)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (1)
- Patient tips
- Drug images
- Compare alternatives
- En español
- Drug class: PI3K inhibitors
- FDA approval history